AtriCure (ATRC) Tops Q4 EPS by 2c ; Offers Guidance

AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $106.5 million versus the consensus estimate of $103.37 million.

GUIDANCE:

AtriCure sees FY2024 EPS of ($0.74)-($0.82), versus the consensus of ($0.69). AtriCure sees FY2024 revenue of $459-466 million, versus the consensus of $458.4 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Credo Technology shares rise on analyst support and conference comments
• HP shares slide as tech giant forecasts 2027 PC market slump